Multidisciplinary Care for Anaplastic Thyroid Cancer-End-of-Life Care as a Standard of Care

By sjmartinez • May 10, 2025

Chen H, Evans L, Schaaff C, Labib M, Oh E, Ashendouek M, Sajed D, Ho WC, Wong DJ, Martin EJ, St John M. Multidisciplinary Care for Anaplastic Thyroid Cancer-End-of-Life Care as a Standard of Care. Laryngoscope. 2025 May 8. doi: 10.1002/lary.32243. Epub ahead of print. PMID: 40342186.

Tags: anaplastic thyroid cancer, end‐of‐life care, goals of care, Hematology/Oncology, hospice, Hospitalist, palliative care, Publications, Pulmonary, Critical Care & Sleep Medicine, targeted therapy

Chemotherapy-Induced Biological Age Acceleration and Lifetime Outcomes in Breast Cancer Survivors

Sarkar S, Sedrak MS, Carroll JE, Schechter C, Muss HB, Mandelblatt JS. Chemotherapy-Induced Biological Age Acceleration and Lifetime Outcomes in Breast Cancer Survivors. JAMA Netw[...]

Engineered stem cell-derived CD16-enhanced universal NKT cells improve monoclonal antibody-based cancer immunotherapy

Li YR, Zhu Y, Yu Y, Kramer A, Shao Z, Chen Y, Shen X, Zhang C, Ma N, Zhao A, Ochoa CJ, DiBernardo GA, Yuen[...]

daNIS-2: a phase III, randomized, double-blind study of the anti-TGF-β monoclonal antibody NIS793 or placebo in combination with nab-paclitaxel/gemcitabine as first-line treatment in patients with metastatic pancreatic ductal adenocarcinoma

Paulson S, Ikeda M, Shen L, Stein A, Macarulla T, Milella M, Golan T, Wainberg Z, Taieb J, Wang L, Polydoros F, Abecunas C, López[...]